Form 4 for LEGN Legend Biotech Corp
Accepted 2026-07-02 16:05:24 ET · period of report 2026-06-30 · accession 0002068365-26-000005 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-07-02 16:05 | 2026-06-30 | LEGN | Casey Patrick John | Dir | S - Sale | $14.80 | -6,000 | 48.6K | -11% | -$88.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Ordinary Shares | 2026-06-30 | S | D | 6,000 | $14.80 | 48,604 | D | — | — | (F1) The Ordinary Shares of the Issuer may be represented by American Depositary Shares ("ADSs"). Each ADS represents two ordinary shares of the Issuer. (F2) The price reported in Column 4 represents the converted sales price of ADSs of $29.60 per ADS (which is equivalent to $14.80 per ordinary share). |